These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38913781)

  • 1. Teratogenicity is more likely a function of primary and secondary pharmacology than caused by chemically reactive metabolites: a critical evaluation of 40 years of scientific research.
    Smith DA
    Xenobiotica; 2024 Jul; ():1-10. PubMed ID: 38913781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice.
    Creech Kraft J; Löfberg B; Chahoud I; Bochert G; Nau H
    Toxicol Appl Pharmacol; 1989 Aug; 100(1):162-76. PubMed ID: 2763297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
    Willhite CC; Lovey A; Eckhoff C
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenicity, tissue distribution, and metabolism of the retro-retinoids, 14-hydroxy-4,14-retro-retinol and anhydroretinol, in the C57BL/6J mouse.
    Mao GE; Collins MD; Derguini F
    Toxicol Appl Pharmacol; 2000 Feb; 163(1):38-49. PubMed ID: 10662603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput screen for teratogens using human pluripotent stem cells.
    Kameoka S; Babiarz J; Kolaja K; Chiao E
    Toxicol Sci; 2014 Jan; 137(1):76-90. PubMed ID: 24154490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative damage in chemical teratogenesis.
    Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
    Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field cyanobacterial blooms producing retinoid compounds cause teratogenicity in zebrafish embryos.
    Pipal M; Priebojova J; Koci T; Blahova L; Smutna M; Hilscherova K
    Chemosphere; 2020 Feb; 241():125061. PubMed ID: 31877619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer.
    Kraft JC; Kochhar DM; Scott WJ; Nau H
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):474-82. PubMed ID: 3470977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryo toxicity and teratogenicity of formaldehyde.
    Thrasher JD; Kilburn KH
    Arch Environ Health; 2001; 56(4):300-11. PubMed ID: 11572272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Origin of Teratogenic Retinoids in Cyanobacteria.
    Sehnal L; Smutná M; Bláhová L; Babica P; Šplíchalová P; Hilscherová K
    Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice.
    Nau H; Löscher W
    Fundam Appl Toxicol; 1986 May; 6(4):669-76. PubMed ID: 3086174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teratogenicity of retinoids detected in surface waters in zebrafish embryos and its predictability by in vitro assays.
    Pípal M; Novák J; Rafajová A; Smutná M; Hilscherová K
    Aquat Toxicol; 2022 May; 246():106151. PubMed ID: 35390581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate.
    Arlen RR; Wells PG
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1649-58. PubMed ID: 8667234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity and dose-response relationships in the neural and behavioral teratogenesis of retinoids.
    Adams J
    Neurotoxicol Teratol; 1993; 15(3):193-202. PubMed ID: 8336680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in harmful drug exposure during pregnancy in France between 2013 and 2019: A nationwide cohort study.
    Louchet M; Collier M; Beeker N; Mandelbrot L; Sibiude J; Chouchana L; Treluyer JM
    PLoS One; 2024; 19(1):e0295897. PubMed ID: 38198446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential teratogenic response of mouse embryos to receptor selective analogs of retinoic acid.
    Kochhar DM; Jiang H; Penner JD; Beard RL; ChandraratnaAS
    Chem Biol Interact; 1996 Mar; 100(1):1-12. PubMed ID: 8599851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical structure--teratogenicity relationships, toxicokinetics and metabolism in risk assessment of retinoids.
    Nau H
    Toxicol Lett; 1995 Dec; 82-83():975-9. PubMed ID: 8597170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites.
    Reist M; Carrupt PA; Francotte E; Testa B
    Chem Res Toxicol; 1998 Dec; 11(12):1521-8. PubMed ID: 9860497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species differences in pharmacokinetics and drug teratogenesis.
    Nau H
    Environ Health Perspect; 1986 Dec; 70():113-29. PubMed ID: 3104022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.